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Abstract: Amphidinols are polyketides produced by dinoflagellates suspected of causing fish kills. 
Here, we demonstrate a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method 
for the identification and quantification of amphidinols (AM). Novel AM were detected by neutral 
loss (NL) scan and then quantified together with known AM by selection reaction monitoring 
(SRM). With the new method, AM were detected in four of eight analyzed strains with a maximum 
of 3680 fg toxin content per cell. In total, sixteen novel AM were detected by NL scan and 
characterized via their fragmentation patterns. Of these, two substances are glycosylated forms. This 
is the first detection of glycosylated AM. 
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1. Introduction 
Amphidinols (AM) are a group of secondary metabolites produced by dinoflagellates of the 
genus Amphidinium. This genus of predominantly benthic species encompasses a number of naked 
and dorsoventrally flatted species of temperate and tropical waters [1]. Phototrophic Amphidinium 
species are important contributors to primary productivity in the interstitial zone and form abundant 
blooms that cause sand discoloration [2]. Amphidinium blooms have also been suspected to be 
associated with fish kills [3]. Based on morphological and phylogenetical evidence, the genus was 
redefined based on rather stringent morphological criteria as species with a minute, crescent-shaped 
or triangular epicone [4]. This “Amphidinium sensu strictu” now includes ca. 20 of the originally 120 
species of the old genus, and many of the other species have been reclassified or are listed as 
“Amphidinium sensu lato” [4,5]. The first AM was reported in 1991 from the cultures of Amphidinium 
klebsii in Japan [6]. The hairpin-shaped polyketides are characterized by a core unit, consisting of two 
tetrahydropyran rings which are separated by a C6 chain, a polyunsaturated (lipophilic) alkyl arm, 
and a long polyhydroxy (hydrophilic) arm [7]. There are several subgroups of the AM family that 
share the same core unit but differ in length and structure of the lipophilic and hydrophilic arm, 
namely amphidinols (AM), luteophanols (LP), lingshuiols (LS), symbiopolyols (SP), karatungiols 
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(KAR), and carteraols (CAR). In contrast, amdigenols (AMD), which also belong to the long-chain 
polyketides, occupy a special position since the extremely large molecules AMD-A and AMD-E are 
composed of two AM core units, which leads to the assumption that they are dimers of AM. AMD-
G, on the other hand, shares the typical AM structure with one core unit [8]. The different names of 
otherwise closely related substances result from the lack of rules for the assignment of trivial names 
to chemical compounds. The rules of systematic nomenclature of chemical compounds established 
by the International Union of Pure and Applied Chemistry (IUPAC) would result in very long and 
unhandy chemical names for such big molecules as AM. For this reason, trivial names for large 
polyketides are commonly used, which only depend on the preference of the researcher describing 
them, often resulting in inconsistencies. For example, the term “luteophanol” was introduced to 
differentiate LP-A from other AM by its terminal sulfate group and several hydroxyl groups on the 
lipophilic arm [9]. In contrast, substances discovered later with the same characteristics were assigned 
to AM (e.g., AM-17 [10] or AM-20 [11]). To avoid confusion, in this work the term “AM” includes all 
compound groups listed above. The majority of AM have been tested for a variety of biological 
activities, with antifungal and hemolytic effects observed in almost all investigated AM, i.e., [12–14]. 
In less frequent cases, cytotoxic and anticancer effects were also found [15,16]. Furthermore, a gill-
damaging and therefore fish-poisonous or ichthyotoxic effect has been found in a not structurally 
elucidated substance, which has a retention time and UV spectrum similar to LP-A [3]. The 
structurally closely-related karlotoxins, produced by species of Karlodinium, have also been shown to 
have an ichthyotoxic effect [17]. Karlodinium appears to use the toxins for prey capture [18], with 
protection against predators being an additional benefit [19]. The toxins create pores in membranes, 
which increase permeability and, consequently, lead to depolarization, motor dysfunction, osmotic 
swelling of the cell, and finally to lysis [17]. Further investigations have shown that the hairpin 
structure and especially the lipophilic polyene part are responsible for the allelochemical effects. For 
example, AM-7 differs from AM-14 only by two hydroxyl groups on the polyene part of the molecule 
but has far stronger hemolytic and antifungal activity [20]. Cholesterol-dependent membrane 
permeabilization properties were also found in several AM analogs [21], but the ecological role and 
benefit of AM has not yet been identified. However, due to the similar chemical structure to the 
karlotoxins, a similar function cannot be eliminated. 
The ability to detect a wide array of structural AM analogs is a prerequisite to investigate the 
biological variability and allelochemical roles of this toxin group and to better understand its effects 
on humans and the environment. This work aimed to develop a standardized and sensitive analytical 
method for the quantification of AM as well as detection of novel AM. Similar methods have been 
successfully established for many shellfish toxins and, more recently, for karlotoxins [22]. To achieve 
the methodological development for AM, we used a purified standard of luteophanol D (LP-D) [11] 
to establish the method for the LC-MS/MS identification and quantification and then applied this 
method to other known members of the AM family. Furthermore, we then used neutral loss scans 
tailored to the fragmentation of known AM to detect novel AM. Finally, the developed methods were 
tested on several available strains of Amphidinium. 
2. Results 
2.1. Adduct Formation of Amphidinols 
For the investigation of the adduct formation of amphidinols (AM) under electrospray ionization 
(ESI) conditions in the ion source of the mass spectrometer, the LP-D standard was tested in the 
Selected Ion Recording (SIR) mode. The mass range of the most common adducts (H+, NH4+, Na+, and 
K+) were scanned. The experiment revealed that the sodium adduct was clearly formed with the 
highest relative abundance (Figure 1). Accordingly, the sodium adduct was selected as the ionized 
species for all other AM for subsequent calculations, investigations, and measurements to achieve 
maximum sensitivity in the detection of this toxin class. 
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Figure 1. Adduct formation of luteophanol D (LP-D) in electrospray ionization (ESI). The highest ion 
yield was recorded for the sodium adduct (M + Na+). 
2.2. Fragmentation Patterns of Amphidinols 
The collision-induced dissociation (CID) spectrum of the sodium adduct of LP-D was 
characterized by a base peak (100% relative abundance) at m/z 903.5 followed by a water loss (18 Da) 
that also was apparent in most of the other fragments and the pseudo-molecular ion (Figure 2). High 
resolution mass spectrometric (HRMS) analysis (Table 1) revealed that the fragment m/z 903.5 was 
formed by the cleavage of the bond C41–C42 in the α-position of the tetrahydropyran ring B (Figure 
3). 
 
Figure 2. High resolution mass spectrometric (HRMS) collision-induced dissociation (CID) spectrum 
of LP-D, tR = 2.00 min. Fragment pairs with a difference of 426 Da are marked in corresponding colors. 
tR = retention time. 
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Table 1. Exact masses, elemental composition, and error between empirical and theoretical masses of 
LP-D fragments. 
m/z Observed Elemental Composition Calculated Exact Mass [Da] ±Da ±ppm 
1329.7548 C66H114NaO25 1329.7549 0.0001 0.08 
1311.7440 C66H112NaO24 1311.7441 0.0001 0.09 
1125.6196 C56H94NaO21 1125.6207 0.0011 0.95 
1055.5768 C52H88NaO20 1055.5769 0.0001 0.13 
1037.5656 C52H86NaO19 1037.5661 0.0005 0.48 
999.5144 C48H80NaO20 999.5147 0.0003 0.34 
911.4613 C44H72NaO18 911.4616 0.0003 0.33 
903.5291 C44H80NaO17 903.5293 0.0002 0.22 
885.5189 C44H78NaO16 885.5190 0.0001 0.16 
837.4247 C41H66NaO16 837.4249 0.0002 0.19 
699.3930 C34H60NaO13 699.3932 0.0002 0.23 
681.3824 C34H58NaO12 681.3826 0.0002 0.29 
629.3509 C30H54NaO12 629.3513 0.0004 0.63 
611.3403 C30H52NaO11 611.3407 0.0004 0.71 
573.2885 C26H46NaO12 573.2887 0.0002 0.34 
485.2361 C22H38NaO10 485.2363 0.0002 0.34 
449.2148 C22H34NaO8 449.2151 0.0003 0.75 
411.1987 C19H32NaO8 411.1995 0.0008 1.91 
 
Figure 3. Fragmentation pattern of LP-D. Fragments, which are formed by cleavages in the 
hydrophilic arm (C10–C25), undergo a second cleavage at the C41–C42 cleavage site, resulting in 
fragment pairs marked in corresponding colors. 
Furthermore, the fragmentation pattern and HRMS analysis evidenced that all fragments 
between the pseudo-molecular ion m/z 1125.6 and m/z 800, with exception of m/z 903.5/885.5, resulted 
from cleavages between C10 and C25. On the other hand, the fragments in the mass range between 
m/z 903.5 and 411, except for m/z 837.4 (which was the result of the cleavage between C24 and C25) 
and m/z 449.2, also resulted from the cleavage between C41 and C42. Accordingly, this fragmentation 
pattern of LP-D resulted in fragment pairs: one fragment with and one without cleavage between 
C41/42. These fragment pairs were labeled with corresponding colors in Figure 3. 
The C41/42 cleavage included the loss of the lipophilic arm (C42–C63) of the molecule and for 
this reason, the mass difference within all fragment pairs was 426 Da, the molecular weight of the 
lipophilic arm. Interestingly, there was only one fragment that did not fit into this pattern, which was 
m/z 449.2. Even though m/z 449.2 also was formed by the C41/42 cleavage, it carried the charge and 
was detected as a fragment in the CID spectrum and not indirectly seen as a neutral loss (NL) as in 
all other cases. 
This result prompted a screen of the available strains by a preliminarily selected reaction 
monitoring (SRM) scan, established on the assumption that all AM sodium adducts form a cleavage 
at the C-C bond in the α-position of the tetrahydropyran ring B (see Section 2.6 for more information 
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about the SRM scan). In this analysis, several known AM could be detected in different strains. CID 
spectra of these AM (AM-22, m/z 1667; LS-A, m/z 1295; LP-B/C, m/z 1343; CAR-E, m/z 1421; AM-4, m/z 
1323; shown in Figure 4) confirmed the fragmentation pattern worked out for LP-D, even though 
some spectra were not well resolved due to low abundance of the substance. Sometimes not visible 
at the first glance, all these spectra contained a fragment that was formed by the cleavage of the C–C 
bond in α-position of the tetrahydropyran ring B (C41–C42), which in the case of LP-D resulted in 
the high abundant fragment m/z 903 (Figure 3). In the spectra of AM-22, LS-A, and LP-B/C, several 
fragment pairs were also visible, even if the heavier fragments resulted from cleavages within the 
hydrophilic arm only appeared in low abundances. As there were structural variations between the 
lipophilic arms of the above-mentioned AM, the mass differences between the ion pairs of each AM 
also varied: 338 Da for AM-22, 392 Da for LS-A, CAR-E, and AM-4, and 440 Da for LP-B/C. Further 
information on spectra and the corresponding fragmentation patterns for the mentioned AM are 
shown in Supplementary Materials Figures S1–S6. 
 
Figure 4. CID-Spectra of amphidinols (AM) were detected in this study. The primary fragment 
occurring in all AM resulting from the C1/C1′ cleavage at the α-position of the tetrahydropyran ring 
B is framed, other fragment pairs are shown in corresponding colors. (a) AM-22, tR = 2.60 min, strain 
DN241EHU and CCMP1314; (b) LS-A, tR = 2.58 min, strain ACRN02; (c) LP-B/C, tR = 2.23 min, strain 
ACRN02; (d) putatively CAR-E, tR = 2.52 min, strain ACRN02; (e) putatively AM-4, tR = 2.62 min, 
strain ACRN02. tR = retention time. 
As there was strong evidence that the C41–C42 cleavage of LP-D was the central fragmentation 
site not only of LP-D but of many—if not all—AM, it could be used as a characteristic feature in the 
interpretation of the CID spectra of AM as it facilitated the recognition of AM and also provided 
information about the structure of the lipophilic arm, which was of high relevance for AM analysis. 
However, as in the literature, the carbon atoms are always numbered in ascending order, from the 
end of the hydrophilic arm to the end of the lipophilic arm, and the arms may vary in their lengths, 
the preferred and conserved cleavage site of AM resulted in different carbon numbers among 
different AM and thus cannot be described uniformly for all AM. For this reason, a new carbon 
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numbering was proposed starting at both sides of the main cleavage site: numbers C1 to Cn for the 
hydrophilic part of AM and C1′ to Cn’ for the lipophilic part. In the following, this modified C-
numbering scheme will be used. 
2.3. Deviating Fragmentation Patterns 
The preliminary SRM scan also revealed some other known AM, which have been identified by 
mass spectrometry by Nuzzo et al. (2014) [7] and Cutignano et al. (2017) [23] before. Their CID spectra 
differ significantly from the AM detected above. In contrast to the fragmentation of LP-D and other 
AM, the CID spectra of AM-18 and AM-A and their sulfated derivatives AM-19 and AM-B, only 
displayed low abundant fragments resulting from the C1′/C1 cleavage, which is m/z 963 for AM-18 
and AM-A, and m/z 945 for AM-19 and AM-B. Instead, they showed additional high abundant peaks 
that distinguish their spectra strongly from those of other AM, e.g., m/z 1163, m/z 1105, and m/z 687 
(Figure 5a). 
 
Figure 5. CID-Spectra of detected AM, which only display low abundant fragments resulting from 
the C1′/C1 cleavage. (a) AM-18, tR = 2.71 min, strain CCMP1314; (b) AM-19, tR = 2.20 min, strain 
CCMP1314; (c) AM-A, tR = 2.76 min, strain DN241EHU (d) AM-B, tR = 2.27 min, strain DN241EHU. tR 
= retention time. 
Pair fragments were also clearly visible in these spectra. The high abundant fragments m/z 1163 
and m/z 1105 for AM-18/AM-19 and m/z 1143 and m/z 1085 for AM-A/AM-B resulted from cleavage 
sites in both β-positions of the carbonyl group at C31 which is flanked by a β-hydroxyl group on each 
side (C29 and C33). AM-18 and AM-19 shared the same lipophilic arm, resulted in a difference 
between the ion pairs of 418 Da, while the difference between the ion pairs of AM-A and AM-B was 
398 Da. Figure 6 shows the fragmentation pattern and the modified C-numbering of AM-18, which 
is representative for AM carrying a carbonyl group that is flanked by the β-hydroxyl group on each 
side. 
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Figure 6. Fragmentation scheme of AM-18, a representative for AM-19, AM-A, and AM-B. The 
fragments m/z 687 and m/z 745 show a difference of m/z 418 to the fragments m/z 1105 and m/z 1163. 
2.4. Neutral Loss (NL) Method for the Detection of Unknown Amphidinols 
To be able to detect unknown AM variants, an LC-MS/MS method in neutral loss (NL) mode 
was developed on the base of the molecular weight of all known lipophilic arms of AM from 
published CID or NMR data that are eliminated during fragmentation as neutral particles by the 
C1/C1′ cleavage. A total of seven different variants of the lipophilic arm occurred in the 37 currently 
known AM. To account also for sulfated AM, a second NL method was set up with an addition of 
120 Da (Table 2).  
Table 2. Masses of different neutral loss (NL) types, which occur in previously discovered AM. In 
addition, the frequencies of the individual NL types in known AM and the masses of the sulfated 
form are shown. 
# Neutral Loss [Da] Observed Frequency Neutral Loss of Sulfated Forms [Da] 
1 392.13 14/37 512.12 
2 426.23 7/37 546.23 
3 418.24 7/37 538.24 
4 398.28 5/37 518.28 
5 440.25 2/37 560.25 
6 442.23 1/37 562.23 
7 338.18 1/37 458.18 
2.5. New Amphidinol Candidates 
Neutral loss experiments of the typical AM losses of 392, 426, 418, 398, 440, 442, and 338 Da, and 
their sulfated types (Table 2), were conducted on the Amphidinium carterae strains ACRN02, ACRN03, 
CCMP1314, DN241EHU, A01BR and on the A. massartii strain AA39, A. operculatum strain AA60, and 
Amphidinium sp. strain AA40. Four candidates (N1–N4) for unknown AM were found in the A. 
carterae strain ACRN02 (Figure 7). They correspond to the LP-D type spectra with one prominent 
fragment resulting from the C1’/C1 cleavage. The substance N1 (m/z 1267, (Figure 7a) was 28 Da 
lower than LS-A (m/z 1295), which was also detected in strain ACRN02 (Figure 4b). N2 (m/z 1429, 
Figure 7b) and N3 (m/z 1457, Figure 7c) were 162 Da higher than N1 and LS-A. High-resolution mass 
spectrometry (HRMS) has shown that the NL part of N2 and N3 with 162 Da corresponded to the 
molecular formula C6H10O5 (Table 3). This formula was consistent with a glucose loss and indicated 
that N2 and N3 were glycosylated forms of N1 and LS-A. 
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Figure 7. CID spectra of new compounds found in A. carterae strain ACRN02. (a) N1, tR = 2.56 min; (b) 
N2, tR = 2.52 min; (c) N3, tR = 2.53 min; (d) N4, tR = 2.16 min. tR = retention time. 
Table 3. Exact masses, elemental composition, and error between theoretical and empirical masses 
for LS-A and N1 to N3. 
Toxin m/z Observed Elemental Composition 
Calculated Exact 
Mass [Da] 
±Da ±ppm 
N1 1267.7164 C64H108Na+O23 1267.7174 0.0010 0.789 
N2 1429.7694 C70H118Na+O28 1429.7702 0.0008 0.560 
LS-A 1295.7481 C66H112Na+O23 1295.7487 0.0006 0.463 
N3 1457.8007 C72H122Na+O28 1457.8015 0.0008 0.549 
A proposed structure and fragmentation scheme for N2, which includes the location of the 
hexose unit, is shown in Figure 8. 
 
Figure 8. Proposed structure and fragmentation scheme of N3, the glycosylated form of N1. 
Furthermore, the presence of the already known AM-18 (m/z 1381 [M + Na]+) was confirmed in 
A. carterae strain CCMP1314 as well as AM-A (m/z 1361 [M + Na]+) in A. carterae strain DN241EHU. 
In this strains, twelve new compounds were detected in total (Figures 9 and 10). CID spectra of the 
new compounds N7 (Figure 9c) and N13 (Figure 10b) correspond to the LP-D type, whereas the other 
new compounds showed a structural pattern of AM-18 with several large peaks resulting from the 
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cleavages in the vicinity of the carbonyl group. Many of the newly detected AM candidates in strains 
CCMP1314 and DN241EHU showed minor mass differences with respect to AM-A and AM-18, 
respectively, such as mass reductions of 18 or 36 Da to AM-18 or AM-A. Moreover, the same fragment 
masses often appeared in different spectra, but their relative abundances varied greatly. 
 
Figure 9. CID spectra of new compounds found in A. carterae strain CCMP1314. (a) N5, tR = 2.17 min; 
(b) N6, tR = 2.72 min; (c) N7, tR = 3.02 min; (d) N8, tR = 2.19 min; (e) N9, tR = 2.78 min; (f) N10, tR = 2.84 
min; (g) N11; tR =2.91 min. tR = retention time. 
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Figure 10. CID spectra of new compounds found in A. carterae strain DN241EHU. (a) N12, tR = 2.21 
min; (b) N13, tR = 3.08 min; (c) N14, tR = 2.23 min; (d) N15, tR = 2.83 min; (e) N16, tR = 2.97 min. tR = 
retention time. 
2.6. Selected Reaction Monitoring (SRM) Method 
An LC-MS/MS method was developed, which included the 37 known AM as well as the new 
AM candidates found in this study (Table 4). This method was applied to different Amphidinium 
strains, which resulted in the detection of 27 different analogs and led to the AM profiles mentioned 
below. 
Table 4. Calculated transitions of already known and newly discovered AM. The fragmentation type 
according to the structure and known retention times are also given. (* = hypothesized transition; (M) 
= detected by Molina-Miras et al. [11]; (S) = detected by Satake et al. [14]; LP-D-type = A; carbonyl type 
= B; other type = C; no further groups = 0; sulfated = 1; glycosylated = 2). 
Toxin 
Q1 
Mass 
(m/z) 
Q3 
Mass 
(m/z) 
Retention 
Time (min) 
Type Toxin 
Q1 
Mass 
(m/z) 
Q3 
Mass 
(m/z) 
Retention 
Time (min) 
Type 
AM-1 * 1511.8 973.6 - A1 
KAR-
B * 
1461.9 1063.6 - B0 
AM-2 * 1397.8 1005.6 - C0 
LP-A 
* 
1277.5 753.5 - A1 
AM-3 * 1349.8 931.6 - A0 LP-B 1343.8 903.5 2.23 A0 
AM-4 1323.8 931.6 2.62 A0 LP-C 1343.8 903.5 2.23 A0 
AM-5 * 1393.8 975.6 - A0 LP-D 1329.7 903.5 2.00 A0 
AM-6 * 1367.8 975.6 - A0 LS * 1373.8 975.6 - B0 
AM-7 * 1253.6 741.5 - A1 LS-A 1295.8 903.5 2.58 A0 
AM-9 * 1349.8 931.6 - A0 LS-B * 1265.6 753.5 - A1 
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AM-10 
* 
1295.8 903.5 - A0 SP* 1265.6 753.5 - A1 
AM-11 
* 
1499.8 987.6 - C1 N1 1267.7 875.5 2.56 A0 
AM-12 
* 
1425.7 913.6 - A1 N2 1429.8 1037.6 2.52 A2 
AM-13 
* 
1451.7 913.6 - A1 N3 1457.8 1065.6 2.53 A2 
AM-14 
* 
1287.6 741.5 - A1 N4 1315.8 875.5 2.16 C0 
AM-15 
* 
1185.7 759.5 - A0 N5 1345.8 945.6 2.17 B0 
AM-17 
* 
1305.7 815.5 - A1 N6 1345.8 945.6 2.72 B0 
AM-18 1381.8 963.6 2.71 B0 N7 1345.8 927.5 3.02 A0 
AM-19 1483.8 945.6 2.20 B1 N8 1363.8 945.6 2.19 B0 
AM-20 
(M) * 
1345.8 903.5 - A0 N9 1363.8 945.6 2.78 B0 
AM-20 
(S) * 
1652.5 1259.8 - A0 N10 1363.8 945.6 2.84 B0 
AM-21 1798.1 1405.9 - A0 N11 1363.8 945.6 2.91 B0 
AM-22 
* 
1667.9 1329.8 2.60 A0 N12 1325.9 945.6 2.21 B0 
AM-A 1361.9 963.6 2.76 B0 N13 1325.9 927.5 3.08 A0 
AM-B 1463.8 945.6 2.27 B1 N14 1343.9 945.6 2.23 B0 
AMD-
G * 
1299.6 767.5 - A1 N15 1343.9 945.6 2.83 B0 
CAR-E 1421.9 1029.6 2.52 C0 N16 1343.9 945.6 2.97 B0 
KAR-A 
* 
1479.9 1081.6 - B0      
2.7. Amphidinol Profiles 
A high diversity of AM variants was found in strain ACRN02. The main components were LS-
A and N1 with together accounted for almost 90% of total AM content, while N3 and N2 occurred in 
significantly lower abundances (N3: 4%, N2: 1%). In addition, LP-D and LP-B/C as well as N6, a 
substance similar to LP-B/LP-C, were detected. Two substances occurring in very small amounts 
(together < 1%) were putatively identified as AM-4 and CAR-E. With a total AM content of 
approximately 3680 fg cell−1, the strain ACRN02 was found to have the highest total toxin content 
within the samples tested (Table 5). Since all quantitation results referred to the LP-D standard, they 
were expressed as LP-D equivalents and have to be regarded estimates. In ACRN03 only LS-A and 
LP-D could be detected in traces (total content 3 fg cell−1). In the A. carterae strain CCMP1314, a total 
AM amount of 1213 fg cell−1 was determined. AM-A and AM-B accounted for 72% of the total AM 
content in this strain, while AM-22 accounted for only 4%. The rest was distributed among the novel 
compounds N5–N11, with N11 being the most abundant of this group, with 15%. The analysis of A. 
carterae strain DN241EHU provided a total AM content of 475 fg cell−1. AM-A and AM-B were 
determined in relative abundances of 25% and 6%, respectively. AM-22 contributed. 2% to the total 
AM content. The remaining portion of about 67% was attributed to the novel compounds N12–N16, 
with N16 accounting for a particularly high proportion of 30% of the total AM content of this strain. 
No AM were detected in the Brazilian A. carterae strain A01BR, in A. massartii strain AA39, in A. 
operculatum strain AA60, and in the Amphidinium sp. strain AA40 from Mexico. 
  
Mar. Drugs 2020, 18, 497 12 of 24 
Table 5. AM cell quotas [fg cell−1] expressed as LP-D equivalents of eight Amphidinium strains 
investigated in this study (- = not detected; * = abundance was too low for unambiguous 
identification). 
Toxin ACRN02 ACRN03 CCMP1314 DN241EHU A01BR AA39 AA40 AA60 
AM-A - - - 121 - - - - 
AM-B - - - 28 - - - - 
AM-4 (*) 4 - - - - - - - 
AM-18 - - 601 - - - - - 
AM-19 - - 266 - - - - - 
AM-22 - - 49 11 - - - - 
CAR-E (*) 2 - - - - - - - 
LS-A 1876 3 - - - - - - 
LP-B/C 53 - - - - - - - 
LP-D 131 < 1 - - - - - - 
N1 1412 - - - - - - - 
N2 39 - - - - - - - 
N3 149 - - - - - - - 
N4 14 - - - - - - - 
N5 - - 12 - - - - - 
N6 - - 3 - - - - - 
N7 - - 14 - - - - - 
N8 - - 29 - - - - - 
N9 - - 53 - - - - - 
N10 - - 9 - - - - - 
N11 - - 177 - - - - - 
N12 - - - 16 - - - - 
N13 - - - 78 - - - - 
N14 - - - 29 - - - - 
N15 - - - 43 - - - - 
N16 - - - 149 - - - - 
∑ 3680 3 1213 475 0 0 0 0 
The limit of detection defined as signal-to-noise ratio = 3 for LP-D in the SRM mode was 
determined as 2.9 pg on-column, which corresponds to 0.08 fg cell−1, based on a cell number of 107 
(roughly applicable to ARCN02, ACRN03, CCMP1314, DN241EHU, and AA39). The lower available 
cell number of strains AA40 and AA60 resulted in a cellular higher detection limit of 0.29 fg cell−1 
(AA40) and 1.62 fg cell−1 (AA60), respectively. The available cell number of A01BR resulted in a 
detection limit of 0.0029 fg cell−1. 
2.8. Hemolytic Activity 
Hemolytic assays with erythrocytes resulted in the following EC50 values for each of the strains: 
9.95 × 106 ± 1.25 × 106 pg of saponin per well (A01BR), 12.25 × 106  1.42 × 106 pg per well (ACRN02), 
15.15 × 106  0.74 × 106 pg per well (ACRN03), 11.78  106  0.52 × 106 pg per well (CCMP1314) and 
8.98 × 106  0.92 × 106 pg per well (DN241EHU). An equivalent saponin potency (pg per A. carterae 
cell) was calculated by dividing the EC50 for saponin by the EC50 for A. carterae. The corresponding 
equivalent saponin potency values for each of the strains were the following: 34  3.5 pg cell−1 
(A01BR), 80.6  11.3 (ACRN02), 245.2  8.4 (ACRN03), 208.8  4.2 (CCMP1314) and 355.6  16.1 
(DN241EHU). These results suggested the presence of hemolytic AM in the methanolic extracts. 
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3. Discussion 
3.1. Ionization and Fragmentation of Amphidinols 
Several AM adducts have been described in the literature: The sodium adduct (+Na+) was used 
to identify AM-A [23], the hydrogen adduct (+H+) for AM-20 [14], and ammonium adduct (+NH4+) 
for AM-22 [16]. However, for a detection method that is both broadly applicable and allows for the 
comparison of ion intensities, it is highly advantageous to focus on one adduct form. This should 
preferably be the adduct form that occurs at the highest abundance and thus allows a high sensitivity. 
In the case of LP-D and the structurally closely-related karlotoxins [22], this applies to the sodium 
adduct (Figure 1). The stabilizing effect of the sodium ion [24] is the reason for the need for relatively 
high collision energies of up to 85 eV for the fragmentation of AM in the collision cell of the tandem 
mass spectrometer. Using the high-resolution CID spectrum of LP-D, it could be shown for the first 
time that almost all relevant fragments are associated with the C1′/C1 cleavage. 
With regard to the deviating fragmentation patterns of AM-18 and AM-A and their sulfated 
forms, AM-19 and AM-B described in Section 2.3, only one fragmentation scheme for AM-18 has been 
presented in the literature by Nuzzo et al. (2014) [7] (Figure 11). This scheme shows some differences 
to the one presented in this work (Figure 6), which makes an exact comparison necessary. 
 
Figure 11. Fragmentation scheme of AM-18 according to Nuzzo et al. [7] with the newly proposed 
carbon numbering system. 
Nuzzo et al. (2014) [7] suggested cleavage sites in both β-positions of the carbonyl group at C31 
flanked by a β-hydroxyl group on each side (C29 and C33) that lead to two of the three most abundant 
fragments (m/z 1163 and m/z 1105). These considerations are consistent with the scheme of this work 
(Figure 6). The third high abundant fragment at m/z 687 is explained by Nuzzo et al. (2014) with a 
C11/C12 cleavage, while the lower abundant fragment m/z 745 is explained with a cleavage of the 
tetrahydropyran ring A between C10 and the ether function (Figure 11). Furthermore, no occurrence 
of fragment pairs is reported in this scheme. However, a closer look at the HRMS data recorded by 
Nuzzo et al. (2014) [7] led to an alternative proposal for the fragments m/z 745 and m/z 687. Nuzzo et 
al. (2014) suggested a composition of C37H70Na+O13 and C35H68Na+O11, respectively (Table 6 (a)). 
According to the newly suspected fragmentation scheme, the fragments m/z 745 and m/z 687 are 
consistent with the elemental compositions of C36H66Na+O14 and C33H60Na+O13 (Table 6 (b)), which in 
turn correspond to the fragment pairs of m/z 1163 and m/z 1105 formed by the C1/C1′ cleavage and 
the loss of the lipophilic arm of AM-18 with a molecular weight of 418 Da (Figure 6). 
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Table 6. Calculated and observed masses of selected peaks of the HRMS spectrum of AM-18. The 
contents in italics originate from Nuzzo et al. [7] (a) fragments according to the fragmentation scheme 
by Nuzzo et al.; (b) fragments according to the newly suspected fragmentation scheme. 
 m/z Observed Elemental Composition 
Calculated Exact 
Mass [Da] 
±Da ±ppm 
(a) 
1381.7755 C71H122Na+O24 1381.8218 0.0463 33.506 
1163.6303 C60H100Na+O20 1163.6700 0.0397 34.116 
1105.5908 C57H94Na+O19 1105.6282 0.0374 33.827 
963.5534 C47H88Na+O18 963.5863 0.0329 34.143 
745.4083 C37H70Na+O13 745.4709 0.0626 83.973 
687.3693 C35H68Na+O11 687.4654 0.0961 139.789 
(b) 
745.4083 C36H66Na+O14 745.4345 0.0262 35.147 
687.3693 C33H60Na+O13 687.3693 0.0233 33.896 
The alternative proposal for the fragments m/z 745 and m/z 687 is further supported by the 
determined deviations between measured and calculated masses of about 35 ppm (Table 6 (b)), which 
fits the deviations between measured and calculated masses of the other described fragments (Table 
6 (a)). 
As AM-A, AM-19, and AM-B also possess a keto group with two β-hydroxyl groups in the 
hydrophilic arm as AM-18 [25], and these three AM differ only slightly from AM-18 in the lipophilic 
arm and/or sulfatation, AM-A, AM-19, and AM-B showed the same fragmentation pattern as AM-18 
(Figure 5). Detailed spectra and fragmentation patterns of these substances are shown in 
Supplementary Materials Figures S7–S10. 
Even though the C1/C1′ cleavage is common among all AM, the relative intensities of the 
respective fragments can vary from the base peak (i.e., 100% relative abundance) to hardly detectable. 
In practical terms, the relative intensities of characteristic fragments should be considered for the 
selection of suitable SRM transitions to ensure the highest sensitivity. This point is particularly 
important as the sensitivity of AM in tandem mass spectrometry is generally low in comparison to 
other phycotoxins and inappropriate transition selection would increase detection limits 
significantly. This specifically applies to AM with a carbonyl group flanked by two hydroxyl groups, 
which display low abundances of the C1/C1′ fragments (Figures 9 and 10). Interestingly, no pair 
fragments were observed for LP-D in the negative ionization mode (Supplementary Materials Figure 
S11), which indicates completely different fragmentations as the positive. 
3.2. Liquid Chromatography-Tandem Mass Spectrometry LC-MS/MS Methods 
For many AM described in the literature, initially, no CID spectra were available as they have 
only been characterized by NMR (e.g., AM-3) [26]. However, structural information of all known AM 
from NMR and CID spectra recorded in this work revealed that the two tetrahydropyran rings and 
the beginning of the lipophilic and hydrophilic arm (C10′–C14) are conserved among AM (except for 
LP-A, missing a hydroxyl group at C8′ [9]), which leads to the conclusion that the C1′/C1 cleavage 
will occur in the fragmentation of these AM. This assumption, together with the structural 
information of AM, allows for the calculation of the m/z values of the fragments formed by the C1′/C1 
cleavage, independent of the availability of mass spectrometric data of these compounds. However, 
it should be considered that sulfated AM always first eliminates the sulfate group before C–C 
cleavages occur. For example, AM-19 with m/z 1483 [M + Na]+ is a sulfated AM. A C1′/C1 cleavage 
would result in the fragment m/z 1065, however, this peak is hardly visible in the CID spectrum of 
AM-19 (Figure 5b). Instead, the cleavage between C1′/C1 occurs after the loss of the sulfate group, 
resulting in fragment m/z 945. The mass difference between the pseudo-molecular ion and the biggest 
fragment is 120 Da corresponding to NaHSO4. Accordingly, m/z values of the characteristic fragments 
were calculated for all AM included in this method and used for the development of a selected 
reaction monitoring (SRM) method for the targeted analysis and determination of all to date known 
AM (Table 4). 
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In addition to the development of the targeted SRM method, the C1′/C1 cleavage can also be 
used for the detection of unknown AM variants based on expected neutral losses (NL scan mode). 
The C1′/C1 cleavage creates a neutral fragment comprising the part from the C-1′ atom to the end of 
the lipophilic arm (for example AM-18: C1′ to C24′, Figure 11). Among the 37 known AM, there are 
only seven structural variants of the lipophilic arm. The molecular weights of these seven neutral 
fragments were calculated accordingly (Table 2) and included in the NL method. Even though this 
NL method is limited to the detection of novel AM containing one of the seven lipophilic arms, the 
probability of being able to detect an unknown AM is quite high because many AM variants include 
only a few structural changes and large parts of the molecules remain conserved. As in the case of 
the SRM method, sulfated AM must be considered separately in the NL method. Sulfated AM can 
only be detected successfully if 120 Da are added to the original neutral losses as the sulfate group is 
split off in addition to the lipophilic arm. 
3.3. Method Advantages and Limitations 
Quantification of phycotoxins depends on the availability of calibration standards. Even though 
isotope-labeled AM have been already used to study their synthetic pathway [27], no isotope-labeled 
AM are commercially available, which could ideally be used as internal standards for toxin 
quantification to avoid matrix effects. Alternatively, the standard addition method could be applied, 
but this method implies a high consumption of standard material, which is not available in most 
cases. Because of the impossibility of internal calibration and the unfeasibility of the standard 
addition method, AM were quantified by external calibration with an LP-D standard instead, and 
AM were expressed as LP-D equivalents, assuming similar molecular responses between LP-D and 
other AM. This assumption is justified by the fact that the fragments used for quantification are based 
on the same C1′/C1 cleavage site in all cases. However, it should be taken into consideration that, in 
the case of particularly large AM (e.g., AM-22, Figure 4a), AM with a carbonyl group (e.g., AM-A, 
Figure 5c), and/or sulfated AM (e.g., AM-B, Figure 5d), the resulting C1′/C1 fragment appears in 
significantly lower abundance than of LP-D. For this reason, all values given as LP-D equivalents are 
not exact determinations, but rather semi-quantitative estimates. In many cases, where analytical 
standards are not available, estimates may be sufficient for many scientific purposes, e.g., for the 
determination of toxin absence/presence, distribution in field samples, or relative variation in profile 
and quantitative composition in laboratory tests. 
In the present SRM method, only a single transition was defined for each AM. In addition, some 
AM have identical masses and possess remarkably similar structures (e.g., AM-3 and AM-9). 
Therefore, in some cases, it is essential to record a CID spectrum for the unambiguous identification 
of the respective AM. In rare cases, however, even a CID spectrum of the sodium adduct is not 
sufficient to distinguish between two substances. For example, LP-B and LP-C differ only in the 
position of two hydroxyl groups on the lipophilic arm, which does not fragment under the conditions 
mentioned above. A CID spectrum in negative mode could make possible an exact distinction, like it 
was the case, for example, in the characterization of AM-7 [13]. Almost all C–C bonds broke so that a 
complete determination of the lipophilic arm was also possible. Moreover, the SRM method easily 
can be expanded by an unlimited number of AM. For this purpose, only the structure of the AM has 
to be known to calculate the m/z value of the fragment resulting from the C1′/C1 cleavage. 
3.4. Characteristics of New Amphidinols 
In summary, the known and newly discovered AM can be assigned to one of two groups. The 
first group describes LP-D-like substances whose CID spectra are usually characterized by a single 
prominent peak. The second group contains mainly AM with a carbonyl group, which has a 
considerable influence on fragmentation and results in several prominent peaks. Sulfated AM appear 
in both groups, and sulfatation is recognized by a pseudo molecular ion with low relative intensity 
and a 120 Da lighter fragment. The spectra of substances N1, N2, N3, N4, N7 and N13 (Figures 7–10). 
can be assigned the LP-D group without sulfur, as the fragments formed by the C1′/C1 cleavage have 
the highest abundance and no peak with a difference of 120 Da to the molecule ion appears. 
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N1 (m/z 1267 [M + Na]+) shows a very similar spectrum to LS-A (m/z 1295 [M + Na]+, Figure 4b) 
and differs from LS-A by the absence of two methyl(ene) groups or one ethyl(ene) group. Both spectra 
are characterized by several identical pair fragments (m/z 1091 and 699, m/z 1021 and 629, m/z 965 
and 573, m/z 803 and m/z 411), which have a difference of m/z 392. The common fragment m/z 415 of 
LS-A and N1, which represents the sodium adduct of C1′–C22′, also indicates that the missing alkyl 
groups must be located on the hydrophilic arm. 
The lower fragments mentioned above (m/z 699, m/z 629, m/z 573, m/z 411) are also present in the 
spectra of N2 and N3 (Figure 7b,c), though the corresponding pair fragments are missing (except for 
m/z 411 in N3). In addition, the masses of the pseudo-molecular ions of N1 and LS-A are present in 
low abundance in the spectra of N2 and N3, respectively, and their mass differences are 162 Da, 
equivalent to C6H10O5 as determined by HRMS (Table 3). This is a strong indication that N2 and N3 
are glycosylated forms of N1 and LS-A, respectively. The high abundance of the C1′/C1 fragments 
m/z 1038 and m/z 1066 that include the hexose unit indicates that this unit is located on the hydrophilic 
arm of both molecules. The glycosylation bond seems to be more stable than the C1′–C1 bond so that 
the C1/C1′ cleavage is preferred over the elimination of the hexose. 
N4 (m/z 1315 [M + Na]+, Figure 7d) shows a difference of m/z 440 between the pseudo-molecular 
ion and the C1′/C1 fragment (m/z 875), which, together with the fragment m/z 463, indicates a neutral 
loss type 5 (Table 2), which otherwise only occurs in LP-B and LP-C. In addition, LP-B/C and N4 
share the pair fragment m/z 1069 and m/z 629. Interestingly, LP-B/C and N4 among the analyzed 
strains were only found in strain ACRN02, which supports the hypothesis that AM variability within 
a strain is based mostly on variations of one core structural element and accordingly structural 
variability within strains is lower than across different strains. However, a crucial difference between 
N4 and LP-B/C is the occurrence of many fragments between m/z 450 and 570 in N4. Such an 
appearance of many fragments in this relatively narrow mass range could not be detected so far in 
other measurements of sodium adducts of AM, which indicates a hitherto unknown modification of 
the hydrophilic arm. 
N7 (m/z 1345 [M + Na]+, Figure 9c) was detected in CCMP1314, while N13 (m/z 1325 [M + Na]+, 
Figure 10b) was detected in DN241EHU. Both substances are the only ones in the respective strains 
that fragment according to the LP-D group with a single large peak besides the pseudo-molecular 
ion. This suggests that these AM candidates, compared to others found in these strains, do not possess 
a carbonyl group flanked by hydroxyl groups. Together with N5, N6, N8, N9, N10, N11, N12, N14, 
N15, and N16 (Figures 9 and 10), N7 and N13 differ in 18 or 36 Da from AM-18 (m/z 1381 [M + Na]+) 
and AM-A (m/z 1361 [M + Na]+), which also were present in high abundances in the respective strains. 
Mass differences of 18 and/or 36 Da often can be attributed to in-source water losses of parent 
compounds, but this can be excluded for the new AM reported here as these AM have different 
retention times and thus must be independent, but closely related variants of AM-18 and AM-A, 
respectively. 
In terms of biosynthetic pathways, the comparison of the AM profiles of strain CCMP1314 and 
DN241EHU is interesting. The main compound of strain CCMP1314 is AM-18 and of strain 
DN241EHU is AM-A. Both AM share the hydrophilic arm and the core unit but differ in the lipophilic 
arm, which in AM18 is longer and has a higher number of double bonds than AM-A. The minor AM 
of both strains (N5, N8, N9, N11 in of CCMP1314 and N12, N14, N15, N16 in DN241EHU) showed 
the same modifications of their respective main AM. N5 (CCMP1314, Figure 9b) and N12 
(DN241EHU, Figure 10a have similar retention times (2.17 min and 2.21 min) and an almost identical 
peak pattern with similar intensities. N12 differs from N5 mainly by the fragments m/z 1049, m/z 1067, 
m/z 1107, and m/z 1325, which are each m/z 20 lighter than the respective fragments from N5. The 
same applies to N8 (2.19 min) and N14 (2.23 min), where the lighter fragments m/z 669, m/z 727, and 
m/z 945 occur in both substances, while the heavier fragments of N8 (m/z 1087, m/z 1145, m/z 1363) 
are increased by m/z 20 regarding N14 (m/z 1067, m/z 1125, m/z 1343). In addition, N14 shows the 
fragment m/z 1085, for which there is no visible corresponding fragment in N8. N9 (2.78 min) and 
N15 (2.83 min) also share a similar peak pattern, including fragments m/z 687, m/z 727, and m/z 945 
in nearly the same intensities. The heavier fragments showed again a difference of 20 Da. Last, N11 
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(2.91 min) and N16 (2.97 min) showed a similar spectrum with only one high intense fragment (m/z 
1105 for N11, m/z 1085 for N16) besides the pseudo-molecular ion. As a result, a corresponding 
fragment with m/z 727 or m/z 745, which occurred in the other substances, is also missing. For the 
compounds N6 and N10, detected in the strain CCMP1314, which were detected only in very small 
amounts, no corresponding substances could be detected in DN241EHU, which could possibly be 
due to the overall lower AM content of DN241EHU. In summary, the similarity between the AM of 
strains CCMP1314 and DN241EHU indicates a conserved biosynthetic pathway in both strains that 
only seem to differ in their polyketide precursor. 
Due to the relatively low number of fragments formed by sodium adducts of AM under CID 
conditions, only limited structural information could be obtained from the spectra. On the other 
hand, the low number of fragments and the characteristic cleavage sites lead to typical fragment 
patterns of AM, which facilitated the recognition and the attribution of unknown compounds to the 
AM compound family and the AM-like CID spectra of N1 to N16 served as strong evidence that the 
newly discovered substances indeed are AM. Nonetheless, the precise structures of the new 
substances can only be verified by nuclear magnetic resonance spectroscopy (NMR). For NMR, 
purified substances are required in sufficiently high amounts, which were not available for this study. 
3.5. Amphidinol Profiles 
AM were detected in four of the eight examined strains. The AM profiles of these strains 
(ACRN02, ACRN03, CCMP1314, and DN241EHU) were dominated by one or two AM as the main 
components and the other AM variants only occurred in small amounts. A similar pattern of 
karlotoxins that are structurally very similar to AM was found in different Karlodinium strains [22]. 
However, the quantitative expression of AM in Amphidinium resulting in varying AM cell quotas 
seems to be variable as ACRN02 in this study showed a higher number and higher AM cell quota 
than ACRN03 (Table 5), which contrast with a previous study that showed that the latter produce 
large amounts of LP-D and LS-A [11]. 
Martínez et al. (2019) previously analyzed the A. carterae strain CCMP1314 and detected AM-18, 
AM-19, AM-22, and other, not further characterized AM-like compounds [16]. This study confirmed 
the presence of AM-18, AM-19, and AM-22 and additionally detected compounds N5–N11, likely the 
AM-like compounds reported earlier [16]. Similarly, AM-A and AM-B were reported for the A. 
carterae strain DN241EHU [28], but no further components were detected. The NL method applied 
here revealed the presence of N12–N16, in addition to AM-22 and the previously reported AM-A and 
AM-B in strain DN241EHU (Table 3). Interestingly, compounds N5–N11 of strain CCMP1314 
followed the same fragment pattern of the major compound AM-18 of this strain (Figure 9). The same 
was observed for strain DN241EHU with AM-A as the main compound and N12–N16 as new AM, 
which presented a similar fragmentation pattern as AM-A (Figure 10). This indicates that the 
chemical variability within one strain is constrained to minor changes of a conserved core structure. 
No AM were detected in strains AA39, AA40, AA60, and A01BR. Only A01BR was identified as 
A. carterae, while AA39 was identified as A. massartii, AA60 as A. operculatum and AA40 as 
Amphidinium sp. To the best of our knowledge, no AM production in A. massartii and A. operculatum 
has been reported so far, which leads to the assumption that not all species of the genus Amphidinium 
produce AM. Nevertheless, no AM might have been found in these strains due to the fact that the 
neutral loss method does not detect unknown AM derivatives with modifications of the lipophilic 
arm. On the other hand, these strains did not show peaks in the mass range most common to AM 
(m/z 1100 and 1700) in high-resolution full-scan mode, indicating that in fact, no AM-like substances 
were present. Another explanation for the absence of AM in the Mexican strains AA39, AA40, AA60 
may be the available biomass ranging from 0.54 × 106 cells (AA60) over 3 × 106 cells (AA40) up to 9 × 
106 cells (AA39), which was lower as for the strains, in which AM could be detected (approximately 
10 × 106 cells). 
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4. Materials and Methods 
4.1. Amphidinium Strains 
General information on Amphidinium strains used in this study are shown in Table 7. The 
Mexican strains AA39 and AA60 were identified as A. massartii and A. operculatum, respectively (in 
process of publication). AA40 is reported as Amphidinium sp. while the detailed morphological and 
molecular designation is performed. 
Table 7. Specifications of different Amphidinium strains analyzed in this study (m = morphological 
identification; g = genetic identification; n.s. = not specified). 
 Amphidinium Provider Origin 
Harvested 
Cells 
ACRN02 
carterae (n.s.) 
Harmful Microalgae Culture 
Collection at IEO (Vigo, Spain) 
La Réunion, 
Ind. Ocean 
10 × 106 
ACRN03 10 × 106 
A01BR Brazil 2.5 × 109 
CCMP1314 carterae (m + g) Bigelow Laboratory (Maine, USA) 
Falmouth Great 
Pond, USA 
10 × 106 
DN241EHU carterae (m + g) 
Culture Collection of the Basque 
Country (Leioa, Spain) 
Punta des Gas, 
Spain 
10.3 × 106 
AA39 massartii (m + g) 
Benthic dinoflagellate collection at 
UNAM, and CICESE (Mexico City, 
Mexico) 
Baja California 
Sur, Mexico 
9 × 106 
AA40 sp. 3 × 106 
AA60 operculatum (m + g) 
Veracruz Reef 
System, Mexico 
0.54 × 106 
4.2. Culture Conditions and Culture System 
The three Mexican strains were maintained in 70 mL plastic culture flasks in a temperature-
controlled culture room at 24 °C, a photon flux density of 70 µE m−2 s−1 on a 16:8 h light:dark 
photocycle in a natural seawater medium prepared with sterile-filtered (0.2 µm VacuCap filters, Pall 
Life Sciences, Dreieich, Germany) Antarctic seawater (salinity: 34, pH adjusted to 8.0) and enriched 
with 1/10 strength K-medium [29]. For toxin analysis, the strains were grown in 300 mL plastic flask 
under the standard culture conditions outlined above. At the stationary phase, cell density (ranging 
from 3 to 30 × 103 cells mL−1) was determined by settling Lugol’s fixed samples and counting > 400 
cells under an inverted microscope. 
Inocula of strains A01BR, ACRN02, ACRN03, DN241EHU, and CCMP1314 were grown in flasks 
at 19 ± 1 °C placed in a thermostated chamber under a 12:12 h light:dark cycle. 58 W fluorescent lamps 
were used for illumination and the irradiance at the surface of the culture flasks was 60 µE m−2 s−1. 
The following culture medium formulations were used: (i) f/2 for the strains CCMP1314 and 
DN241EHU [30]; (ii) modified K medium for the strains A01BR, ACRN02, and ACRN03 [11]. Media 
prepared from natural, filter-sterilized (0.22 µm) Mediterranean seawater was used to maintain the 
inocula. Inocula were acclimated to the illumination level and culture media above mentioned for 
more than a year. Monocultures of A01BR, ACRN02, ACRN03, DN241EHU, and CCMP1314 were 
conducted at 19 ± 1 °C in methacrylate bubble column photobioreactors (BCs) similar to those earlier 
reported [31]. Briefly, BCs with a volume of 3.0 L (2 m high, 0.044 m internal diameter) were 
positioned vertically at a distance of 0.3 m from the light source. Illumination was provided by 58W 
fluorescent lamps emitting an average irradiance at the surface of the columns of 60 µE m−2 s−1. 
Cultures were pneumatically agitated by filter-sterilized air sparged through a nozzle with 1.5 mm 
internal diameter. Prior to use, the BCs were sterilized by filling the vessels and associated pipework 
with filtered seawater, adding commercial bleach (~3 mL per L of water), mixing gently, and letting 
stand (no mixing or aeration) for several hours. Once the treatment had been completed, the bleach 
was neutralized by adding a solution of sodium thiosulfate (250 g sodium thiosulfate (Na2S2O3·5H2O) 
dissolved in 1 L of water; 1 mL of this solution was added for each 4 mL of the bleach used). The 
culture medium was prepared as described above. The fresh medium was inoculated with 10% v/v 
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of an inoculum containing algal cells in the late exponential growth phase. Cultures were operated 
in batch mode. 
A Cell Lab Quanta SC flow cytometer (Beckman Coulter Inc., Brea, CA, USA) was used to 
quantify the cell density in the cultures. At least 60,000 cells were counted per sample. Triplicate 
samples were measured, and the data were averaged. The flow rate was kept at a moderate setting 
(data rate = 600 events s−1) to prevent interference between cells. 
4.3. Hemolytic Activity 
The assay for the detection of hemolytic activity of the methanolic extracts of strains A01BR, 
ACRN02, ACRN03, DN241EHU, and CCMP1314 was performed as described by Eschbach et al. 
(2001) [32]. In short, a sample of the methanolic extract was placed in a microwell and air-dried. 
Erythrocytes from defibrinated sheep blood were used at a concentration of 45 × 106 cells per well. 
Erythrocytes incubated in Mediterranean seawater served as negative controls, and the positive 
control, or 100% hemolysis, was obtained using distilled water. The dose-response curves (percentage 
of hemolysis (PH) vs. log of number of A. carterae cells per well (x)) were fitted to the Hill equation 
by nonlinear regression: 
PH =  PH    + 
PH     − PH   
1 +  x EC   
 
 
 
 (1) 
where PHmax is the maximum percentage of hemolysis equal to 100%, EC50 is the number of A. carterae 
cells per well giving 50% hemolysis and η is the Hill slope. The Hill curve was also applied to 
hemolysis experiments with Saponin (Sigma Aldrich, 47036, CAS nº 8047-15-2, Saint Louis, MO, 
USA). 12 data points were used for both, sample and saponin curve. The range of concentrations was 
0–229 µg saponin/well and 0–105 cells/well. 
4.4. Chemical Analysis 
4.4.1. Harvest of Amphidinium Cells 
Cells of the Mexican strains were harvested by centrifugation at 5250× g and 10 °C for 15 min in 
an Allegra X-15 R laboratory centrifuge (Beckman Coulter GmbH, Krefeld, Germany) and the 
supernatant was removed. After a short resuspension, the samples were pelleted again at 16,100× g 
and 10 °C for 15 min and the supernatant was decanted. 
Once the stationary phase of strains A01BR, ACRN02, ACRN03, DN241EHU, and CCMP1314 
was reached, the cultures were deposited in 50 mL Falcon tubes and centrifuged at 2500× g for 5 min 
at room temperature in a benchtop centrifuge (Beckman Coulter, model Allegra 25R, Madrid, Spain) 
using a rotor (swing-out head) with a maximum radius of 13.7 cm (max RCF = 15,300× g). These 
centrifugation conditions were within the operating window previously determined for Amphidinium 
carterae where maximum cell recovery and cell separation-cell integrity are guaranteed [33]. The 
pellets were gently washed with distilled water. Cells were again pelleted, and the supernatants were 
carefully removed. The frozen biomass pellets were dried in a vacuum freeze-dryer (Cryodos 50, 
Telstar, Madrid Spain) for 48 h. 
4.4.2. Extraction of Amphidinols 
AA39, AA40, AA60 
The cells of Amphidinium sp. strains AA39, AA40, and AA60 were extracted by addition of 500 
µl methanol and 0.9 g Lysing Matrix D and suspension on a vortexer followed by lysis by reciprocal 
shaking at maximum speed (6.5) for 45 s in a Bio 101 FastPrep device (Thermo Savant, Illkirch, 
France). Solid cell residues and Lysing Matrix D were then separated from the methanol extract by 
centrifugation at 16,100× g and 10 °C for 5 min. The methanol extract was transferred to a 
centrifugation filter (Ultrafree, Millopiore, Eschborn, Germany) with a pore size of 0.45 µm and 
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centrifuged at 16,100× g and 10 °C for 1 min. Finally, the filtrate was transferred to an HPLC vial and 
sealed with a lid containing a silicone septum. Samples were stored at −20 °C until analysis. 
ACRN02, ACRN03, CCMP1314 and DN241EHU 
The dried biomasses were extracted three times with 15 mL methanol (methanol:biomass ratio 
of 30 (v/d.w.)). The extraction process was ultrasonication-aided by an ultrasonic probe-type device 
(UP200S, Hielscher Ultrasonics™; 200 W, 24 kHz, 4 min, Hielscher, Teltow, Germany). The sonication 
power was 50% of full power, and the pulse control was set at 0.5. The sonicated suspensions were 
centrifuged (4000× g, 10 min, 10 °C), the methanolic supernatants were recovered and filtered (0.22 
µm pore size membrane filter) to remove debris. For every strain, aliquots equivalent to 107 cells were 
dried under an N2 stream and used as a raw material in the LC-MS/MS-based detection method. After 
shipment from University of Almería (Spain) to Alfred-Wegener-Institute (Germany), the dry 
extracts were dissolved in 400 µL methanol, each tube was washed twice with additional 400 µL and 
combined extracts of each strain were transferred to an HPLC sample vessel. Methanol was 
completely evaporated under a fume hood with nitrogen. The residues were then dissolved with 100 
µL methanol and transferred to a centrifugation filter with a pore size of 0.45 µm. The HPLC sample 
tubes were rinsed again with 50 µL methanol and the resulting extracts were also transferred to the 
centrifugation filter. Extracts were centrifuged at 16,100× g and 10 °C for 1 min to remove suspended 
solids. Finally, the filtrates were transferred to conical HPLC sample tubes and closed with a lid 
containing silicone septum. Samples were stored at −20 °C until measurement. 
A01BR 
After adding 5 mL methanol to the pellet of the A. carterae strain A01BR, it was digested for 1 
min with an ultrasonic rod (SONOPLUS HD2070 MS72, Bandelin electronic, Berlin, Germany) at 70% 
cycle and 72% power. By short vortexing, the cells located on the wall of the tube were rewound back 
into the solution and the ultrasonic treatment was repeated under the same settings. The sample was 
then centrifuged at 5250× g for 5 min (Allegra X-15 R laboratory centrifuge, Beckman Coulter GmbH, 
Krefeld, Germany). The supernatant was divided in equal parts into four HPLC vial and sealed with 
silicone septum lids. These were stored at −20 °C until further use. From one of the aliquots, 300 µL 
were taken and transferred to a 0.45 µm centrifugation filter. After centrifugation filtration at 16,100× 
g and 10 °C for 1 min, the sample was placed in a conical HPLC vial and closed with a lid with silicone 
septum. Since the measurement of the centrifugation-filtered sample did not yield positive results, 
the four extracts were combined and concentrated. For this purpose, the extracts were combined in a 
15 mL centrifuge tube (approx. 4.5 mL) and the methanol was evaporated stepwise with nitrogen. 
The residues were finally dissolved with 500 µL methanol and divided equally between two HPLC 
sample tubes. The centrifuge tube was then rinsed twice with 100 µL methanol each and this was also 
divided between the two HPLC sample tubes. From one of the two aliquots, 200 µL were then 
centrifugation-filtered according to the previously mentioned scheme and stored at −20 °C until 
measurement. 
4.4.3. LC-MS/MS Analysis 
Ultra-Performance Liquid Chromatography (UPLC®) coupled with tandem quadrupole mass 
spectrometry was used for AM analysis. The UPLC system comprised an AQUITY UPLC column 
oven, an AQUITY I UPLC class autosampler (operating temperature 8 °C) and an AQUITY I UPLC 
class binary pump. Separation of the methanol extract was performed after injection of 0.5 µL sample 
by a Purospher®STAR RP-18 endcapped (2 µm) Hibar® HR 50-2.1 UPLC column (Merck, Darmstadt, 
Germany), which was maintained at 40 °C. A 0.5 µm OPTSSOLV ® EXP™ precolumn (Sigma-Aldrich, 
Hamburg, Germany) was used. This system was coupled to a Xevo® TQ-XS mass spectrometer 
(Waters GmbH, Eschborn, Germany). Data were collected and analyzed with Masslynx software 
(version 4.2, Waters). The flow rate was 0.6 mL min−1, and gradient elution was performed with two 
eluents, where eluent A was water and eluent B was acetonitrile/water (9:1 v/v), both containing 6.7 
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mM ammonia. The gradient was as follows: The measurement was initialized with 70% A until 1.5 
min, followed by a linear gradient to 10% A until 3.5 min. This condition was maintained until 4.0 
min and the gradient was then returned to initial conditions until 4.1 min. These settings were 
retained up to 5.0 min (= total running time). For NL-, CID- and SRM-scans, the collision energy for 
sulfated AM and AM with carbonyl group was 75 eV, while for AM with a similar structure to the 
standard substance LP-D, a collision energy of 85 eV was used. All measurements were performed 
in positive mode. The used neutral losses and transitions for SRM are given in Tables 2 and 4. CID 
spectra were recorded of the [M + Na]+ adduct ions of all available compounds. Further mass 
spectrometric parameters are given in Table 8. 
Table 8. Mass spectrometric parameters for the detection of amphidinols (AM). 
Ion-Source 
Capillary Voltage [kV] 2.00 
Cone Voltage [kV] 45 
Desolvation Temperature [°C] 600 
Gas Flow 
Desolvation [L/h] 1000 
Cone [L/h] 150 
Nebulizer [bar] 7.0 
4.4.4. High-Resolution Mass Spectrometry 
LC-HRMS analysis was performed with a Vanquish UPLC system coupled to a Q-Exactive Plus 
mass spectrometer, using a heated electrospray ionization source (both Thermo Fisher Scientific, 
Bremen, Germany). Separation was performed using a binary solvent gradient with solvent A = 0.1% 
formic acid in ultrapure water and solvent B = 0.1% formic acid in methanol with a flow rate of 0.4 
mL min−1 on a C18 column (C18 BEH, 100 × 2 mm, 1.7 µm particle size, ACQUITY Waters, Eschborn, 
Germany, equipped with guard-column) at 32 °C. The gradient program was as follows: T0 min: B = 
5%, T0.1 min B = 5%, T3 min: B = 99%, T5min: B = 99%; T5.2 min: B = 5%. The column was equilibrated for 1 
min between samples. MS2 spectra were acquired by the data-dependent (dd-MS²) or data-
independent (DIA) mode. dd-MS² experiments were performed with a full scan at resolution (RES) = 
140,000 followed by dd-MS² at NCE (normalized collision energy) of 45, automatic gain control 
(AGC) of 2e5, isolation window (IW) of 1.0 m/z, injection time (IT) of 50 ms, a RES = 70,000 full width 
at half maximum (FWHM) an inclusion list of accurate masses. DIA experiments also utilized an 
inclusion list of accurate masses (four entries maximum) at a resolution of 280,000 (m/z 200), stepwise 
normalized collision energy (NCE) 40, 50 and 55, automatic gain control (AGC) target of 2e5 and 
isolation window of 0.8 m/z. The spray voltage for all experiments was 3.5 kV. The capillary 
temperature was set to 256 °C, the aux gas to 413 °C (11) and the sheath gas to 48. Positive Ion 
Calibration Solution (Pierce, Thermo Fisher Scientific) was used for the calibration of the instrument. 
Molecular Assignment for the molecular formulas of the [M + Na]+ ions were accepted when within 
the mass tolerance range of the instrument’s error (<1ppm). 
5. Conclusions 
The thorough analysis of the fragmentation patterns of AM and related compounds allows for 
the identification of new structural variants of this toxin group by mass spectrometry. This is 
particularly useful as NMR, the classical method for structural elucidation of unknowns requires 
relatively high amounts of purified compounds, which in many cases are difficult to obtain. In the 
case of AM, the number of unidentified structural variants and therefore the number of compounds 
with varying degrees of biological activity may be high and depending on the producing species and 
geographic origin. Further, the molecular size of these polyketides allows for a high structural 
variability as seen in other classes such as yessotoxins [34] and prymnesins [35]. The high structural 
similarity of AM to karlotoxins suggests that AM may be involved in predation and grazing defense 
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by membrane lysis of other protistan organisms. The biological activity of the glycosylated AM first 
described here is especially intriguing for further investigations. Whereas other more polar AM such 
as the sulfated forms were not biologically active in in vitro, nothing is known on the toxicity of 
glycosylated AM. One hypothesis for the biological inactivity of sulfated and most likely also of 
glycosylated AM may be that these polar AM are biosynthetic precursors that prevent self-
intoxication of the producing cells. 
Supplementary Materials: The following are available online at www.mdpi.com/xxx/s1, Figure S1–S11: CID-
spectra and fragmentation pattern of detected AM. 
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